SpringWorks Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. SpringWorks Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11% to $5,447,000. Profit margin reached -5968%. Total operating expenses were $348,038,000.
Profit Margin
| 2017 | 0 | -4.63M | |
|---|---|---|---|
| 2018 | 0 | -17.81M | |
| 2019 | 0 | -54.75M | |
| 2020 | 35M | -44.24M | -126.41% |
| 2021 | 0 | -173.21M | |
| 2022 | 6.14M | -274.16M | -4460.06% |
| 2023 | 5.44M | -325.10M | -5968.5% |
SWTX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 5.44M | 6.14M | 0 | 35M | 0 | 0 | 0 |
Cost of revenue | 422K | 1.89M | 490K | 349K | 192K | 0 | 3.18K |
Gross profit | 5.02M | 4.25M | -490K | 34.65M | -192K | 0 | -3.18K |
Operating exp. | |||||||
Research and development | 150.48M | 146.12M | 101.67M | 51.85M | 42.54M | 9.89M | 2.79M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | -3.72M |
Total operating expenses | 348.03M | 280.67M | 173.46M | 81.32M | 59.23M | 18.49M | 4.65M |
Operating income | -343.01M | -280.67M | -173.46M | -46.32M | -59.23M | -18.49M | -4.66M |
Other income (expenses), net | 17.90M | 3.25M | -442K | 750K | 933K | 678K | 21K |
Income before tax | -325.10M | -277.41M | -173.91M | -45.57M | -58.30M | -17.81M | -4.63M |
Income tax expense | 0 | -3.25M | -698K | -1.33M | -3.54M | 678K | -2 |
Net income | -325.10M | -274.16M | -173.21M | -44.24M | -54.75M | -17.81M | -4.63M |
Earnings per share | |||||||
Basic EPS | -5.15 | -5.14 | -3.57 | -1.02 | -1.27 | -0.8 | -0.11 |
Diluted EPS | -5.15 | -5.14 | -3.57 | -1.02 | -1.27 | -0.8 | -0.11 |
| Data source | Data source | Data source | Data source | Data source |